San Chem Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.90 M
- Company Age 41 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.10 M
- Revenue Growth %
- Profit Growth 90.10%
- Ebitda 99.74%
- Net Worth -0.00%
- Total Assets -0.00%
About San Chem Pharma
San Chem Pharma Private Limited (SCPPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 July 1983 and has a history of 41 years and six months. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.90 M.
The company currently has active open charges totaling ₹0.10 M.
Satish Bharadwa and Deepakkumar Mistry serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24231GJ1983PTC006362
-
Company No.
006362
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Jul 1983
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at San Chem Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satish Bharadwa
|
Director | 28-Aug-2016 | Current |
|
Deepakkumar Mistry
|
Director | 04-Aug-2017 | Current |
Financial Performance of San Chem Pharma.
San Chem Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 90.1% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of San Chem Pharma?
In 2023, San Chem Pharma had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.10 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of Saurashtra : 0.01 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Mar 1989 | State Bank Of Saurashtra | ₹0.05 M | Open |
| 27 Mar 1984 | State Bank Of Saurashtra | ₹0.05 M | Open |
How Many Employees Work at San Chem Pharma?
Unlock and access historical data on people associated with San Chem Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of San Chem Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped San Chem Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
